Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2025-12-30 @ 3:35 AM
Study NCT ID:
NCT00086632
Status:
TERMINATED
Last Update Posted:
2007-12-18
First Post:
2004-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment
Sponsor:
Unither Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-12
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-07
First Submit QC Date:
None
Study First Post Date:
2004-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-12-13
Last Update Post Date:
2007-12-18
Last Update Post Date Type:
ESTIMATED